Is it time to rethink the Alzheimer’s disease drug development strategy by targeting its silent phase?
Benoit Souchet, Mickael Audrain, Baptiste Billoir, Laurent Lecanu, Satoru Tada, Jérôme Braudeau
Neural Regeneration Research . 2018, (
2
): 224 -225 . DOI: 10.4103/1673-5374.226389